Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Doug Ingram
Doug Ingram
Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug
Stat
Thu, 11/7/19 - 10:58 pm
Sarepta Therapeutics
Doug Ingram
FDA
Vyondys 53
Duchenne Muscular Dystrophy
Sarepta CEO Doug Ingram scored a chart-topping $57M compensation deal in 2017. Earning it won’t be easy
Endpoints
Fri, 05/4/18 - 06:45 pm
Sarepta Therapeutics
Doug Ingram
executive pay
Allergan vet Doug Ingram takes the helm of a storm-tossed Sarepta
Endpoints
Thu, 06/29/17 - 09:10 am
Allergan
Sarepta Therapeutics
Doug Ingram
Ex-Allergan prez Ingram forges $1B deal to sell Alzheimer’s biotech to Brent Saunders and the new crew at Allergan
Endpoints
Tue, 11/22/16 - 09:55 pm
Allergan
Brent Saunders
Doug Ingram
Alzheimer's disease
Chase Pharmaceuticals
How the Actavis deal upended Allergan No. 2's CEO ambitions
Yahoo/Reuters
Wed, 02/4/15 - 09:58 am
Allergan
Amgen
M&A
Doug Ingram